Amgen will lay off a small number employees from Dublin-headquartered Horizon Therapeutics next year, after closing its $27.8bn (€26.3bn) acquisition of the rare-disease drugmaker earlier this ...
The agency gave Akebia’s drug an OK after receiving more safety data, but imposed a strict boxed warning for its use that may limit uptake.
Two months after closing its multibillion-dollar acquisition of Mirati Therapeutics, Bristol Myers Squibb is bidding adieu to ...
Arrakis Therapeutics parted ways with about 20% of its workforce last week. CEO Michael Gilman confirmed the layoffs to the Business Journal on Monday, writing in an emailed statement that the ...
Amgen is arguably one of the most impressive companies in its industry. The pharma giant topped the analyst consensus for both revenue and non-GAAP EPS in Q4. Amgen's debt is rated investment ...
At Argus Research, Jasper covers the Growth Pharmaceutical, Medical Technology, and Financial Technology companies. He received his undergraduate degree from Boston University, graduating cum ...
Amgen today is the biggest biotechnology company in the world, but its plush headquarters, global reach and tens of thousands of employees belie its humble origins. Founded in 1980 as Applied ...
It has been about a month since the last earnings report for Amgen (AMGN). Shares have lost about 6.5% in that time frame, underperforming the S&P 500. Will the recent negative trend continue ...
The national debt is over $34 trillion, consumer credit card debt is a staggering $1.13 trillion, and many companies ...
ANNOUNCER: 'Think Tank' has been made possible by Amgen, arecipient of the Presidential National Medal of Technology. Amgen,bringing better, healthier lives to people worldwide throughbiotechnology.
Gilead Sciences announced a research collaboration, option and license agreement with Merus N.V. to discover novel dual tumor-associated antigens targeting trispecific antibodies – which could exceed ...
The Artificial Intelligence rally over the last year, led by the so-called “Magnificent 7,” has been fantastic if you owned those stocks. However, most of the S&P 500 is treading water and ...